ACS Symposium Series
eBook - PDF

ACS Symposium Series

  1. English
  2. PDF
  3. Available on iOS & Android
eBook - PDF

ACS Symposium Series

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access ACS Symposium Series by Jaan A. Pesti,Ahmed F. Abdel-Magid,Rajappa Vaidyanathan,Matthew Maddess,John McIntosh,Wonsuk Chang,Trung Cao,Natalia Dyatkina,Sébastien Lemaire,Marija Prhavc,Simon Wagschal,Jun Liang,Jie Xu,Scott H. Watterson,Steven R. Wisniewski,Seb Caille,Brian S. Lucas,T. G. Murali Dhar,William P. Gallagher,John , Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan, Jaan A. Pesti,Ahmed F. Abdel-Magid,Rajappa Vaidyanathan in PDF and/or ePUB format, as well as other popular books in Physical Sciences & Chemistry. We have over one million books available in our catalogue for you to explore.

Information

Publisher
American Chemical Society
Year
2022
Print ISBN
9780841297326
eBook ISBN
9780841297326
Topic
Physical Sciences
Subtopic
Chemistry
Index
Chemistry

Table of contents

  1. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry. Volume 4
  2. ACS Symposium Series1423
  3. Foreword
  4. Preface
  5. Discovery and Chemical Development of Uvelostinag (MK-1454): A Therapeutic Cyclic Dinucleotide Agonist of the Stimulator of Interferon Gene
  6. Discovery and Chemical Development of Adafosbuvir, a Nucleoside Phosphoramidate Prodrug for the Treatment of Hepatitis C Infection
  7. Discovery and Development of a Highly Potent, Orally Bioavailable Estrogen Receptor Full Antagonist and Degrader: Giredestrant (GDC-9545) for Estrogen Receptor-Positive Breast Cancer
  8. A Twisted Road to the Discovery and Chemical Development of BMS-986142: A Reversible Inhibitor of BTK Conformationally Constrained by Two Rotationally Stable Atropisomeric Axes
  9. Discovery of AMG 232, a Small Molecule Disrupting the p53-MDM2 Protein–Protein Interaction and Development of a Validation-Ready Process for Its Manufacture
  10. The Discovery and Chemical Development of BMS-986251: A Selective RORγt Inverse Agonist for the Potential Treatment of Autoimmune Diseases
  11. Discovery and Chemical Development of Amcenestrant: An Oral Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
  12. Development and Optimization of the Manufacturing Process for RNA-Splicing Modifier Risdiplam RG7916
  13. Past, Present, and Future: A Changing Paradigm for Process Chemistry
  14. Editors’ Biographies
  15. Indexes
  16. Author Index
  17. Subject Index
  18. Preface
  19. Discovery and Chemical Development of Uvelostinag (MK-1454): A Therapeutic Cyclic Dinucleotide Agonist of the Stimulator of Interferon Gene
  20. Discovery and Chemical Development of Adafosbuvir, a Nucleoside Phosphoramidate Prodrug for the Treatment of Hepatitis C Infection
  21. Discovery and Development of a Highly Potent, Orally Bioavailable Estrogen Receptor Full Antagonist and Degrader: Giredestrant (GDC-9545) for Estrogen Receptor-Positive Breast Cancer
  22. A Twisted Road to the Discovery and Chemical Development of BMS-986142: A Reversible Inhibitor of BTK Conformationally Constrained by Two Rotationally Stable Atropisomeric Axes
  23. Discovery of AMG 232, a Small Molecule Disrupting the p53-MDM2 Protein–Protein Interaction and Development of a Validation-Ready Process for Its Manufacture
  24. The Discovery and Chemical Development of BMS-986251: A Selective RORγt Inverse Agonist for the Potential Treatment of Autoimmune Diseases
  25. Discovery and Chemical Development of Amcenestrant: An Oral Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
  26. Development and Optimization of the Manufacturing Process for RNA-Splicing Modifier Risdiplam RG7916
  27. Past, Present, and Future: A Changing Paradigm for Process Chemistry
  28. Editors’ Biographies
  29. Indexes
  30. Author Index
  31. Subject Index